despair test. Japan. J. Pharmacol. 35, 67-7
(1984) 2
4 Araki, H., Kawashima, K., Uchiyama, Y. and 10
Aihara, H.: Involvement of amygdaloid catechol
aminergic mechanism in suppressive effects of
desipramine and imipramine on duration of
immobility in rats forced to swim. Eur. J. Phar 11
macol. 113, 313-318 (1985)
5 Kawashima, K., Araki, H., Uchiyama, Y. and
Aihara, H.: Amygdaloid catecholaminergic mech
anisms in suppressive effects of electroconvulsive
shock on duration of immobility in rats forced to
swim. Eur. J. Pharmacol. 141, 1-6 (1987)
6 Biziere, K., Kan, J.P., Souilhac, J., Muyard, J.P.
and Roncucci, R.: Pharmacological evaluation of
minaprine dihydrochloride, a new psychotropic 12
drug. Arzneimittelforschung. 32, 824-831 (1982)
7 Mikus, P., Biziere, K. and Bentel, U.: Double
blind study of minaprine versus nomifensine in
patients with a masked depression. International
Symposium at the First European Conference on
Minaprine, Vienna, p. 41-54 (1984) 13
Peselow, E.D. and Stanley, M.: Clinical trials of
benzamides in psychiatry. Adv. Biochem.
Psychopharmacol. 35, 163-194 (1982)
Konig, J.F.R. and Klippel, R.A.: The Rat Brain:
